Myra Vision

Private

Campbell, CaliforniaHealthcare & Life Scienceshttps://www.myravision.com/

Last Round

Series B

Jun 26, 2023

Total Funding Raised

$45.16M

Company Overview

Myra Vision is a healthcare company that develops innovative surgical techniques and medical devices aimed at enhancing treatment options for glaucoma patients by effectively reducing intraocular pressure while minimizing the risk of complications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

glaucoma surgeryaqueous shunttitratable glaucoma therapyintraocular pressure managementminimally invasive glaucoma surgeryMIGSophthalmic devicesurgical implantglaucoma drainage devicemedical deviceophthalmologyclinical trialmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myra Vision Comps

Public and private peers based on sector, stage, and business model.

Myra Vision comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Myra Vision Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jun 26, 2023
Series A	Jun 1, 2021
Seed	Oct 10, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Claudio Argento

CTO - Co-Founder

Founding Team

Robert Chang

President & CEO

Executive Team

Myra Vision Investors

Notable investors and investment history

Myra Vision investors
Investor	Rounds
Shifamed	Series B, Series A, Seed
Cormorant Asset Management	Series A, Series B
Cormorant Capital	Series A
The Capital Partnership	Series B, Series A
PA MedTech VC Fund	Series B
Cormorant Asset Management	Series A, Series B
Picard Angst	Series B

View all Investors

Myra Vision Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Myra Vision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myra Vision's valuation, stock price, and market status.

Firmographic Details

HeadquartersCampbell, California

Employee Range26

Year Founded2019

Last FundingJun 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.